Your browser doesn't support javascript.
loading
Correction to: Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification.
Keck, Michaela-Kristina; Sill, Martin; Wittmann, Andrea; Joshi, Piyush; Stichel, Damian; Beck, Pengbo; Okonechnikow, Konstantin; Sievers, Philipp; Wefers, Annika K; Roncaroli, Federico; Avula, Shivaram; McCabe, Martin G; Hayden, James T; Wesseling, Pieter; Øra, Ingrid; Nistér, Monica; Kranendonk, Mariëtte E G; Tops, Bastiaan B J; Zapotocky, Michal; Zamecnik, Josef; Vasiljevic, Alexandre; Fenouil, Tanguy; Meyronet, David; von Hoff, Katja; Schüller, Ulrich; Loiseau, Hugues; Figarella-Branger, Dominique; Kramm, Christof M; Sturm, Dominik; Scheie, David; Rauramaa, Tuomas; Pesola, Jouni; Gojo, Johannes; Haberler, Christine; Brandner, Sebastian; Jacques, Tom; Sexton Oates, Alexandra; Saffery, Richard; Koscielniak, Ewa; Baker, Suzanne J; Yip, Stephen; Snuderl, Matija; Ud Din, Nasir; Samuel, David; Schramm, Kathrin; Blattner-Johnson, Mirjam; Selt, Florian; Ecker, Jonas; Milde, Till; von Deimling, Andreas.
Afiliación
  • Keck MK; Hopp Children's Cancer Center Heidelberg (KiTZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.
  • Sill M; Division of Pediatric Glioma Research (B360), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.
  • Wittmann A; Hopp Children's Cancer Center Heidelberg (KiTZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.
  • Joshi P; Division of Pediatric Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Stichel D; Hopp Children's Cancer Center Heidelberg (KiTZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.
  • Beck P; Division of Pediatric Glioma Research (B360), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.
  • Okonechnikow K; Hopp Children's Cancer Center Heidelberg (KiTZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.
  • Sievers P; Department of Neuropathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
  • Wefers AK; Clinical Cooperation Unit Neuropathology, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Roncaroli F; Hopp Children's Cancer Center Heidelberg (KiTZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.
  • Avula S; Division of Pediatric Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • McCabe MG; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.
  • Hayden JT; Hopp Children's Cancer Center Heidelberg (KiTZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.
  • Wesseling P; Division of Pediatric Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Øra I; Department of Neuropathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
  • Nistér M; Clinical Cooperation Unit Neuropathology, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Kranendonk MEG; Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Tops BBJ; Geoffrey Jefferson Brain Research Centre, Division of Neuroscience and Experimental Psychology, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
  • Zapotocky M; Department of Radiology, Alder Hey Children's NHS Foundation Trust, Liverpool, UK.
  • Zamecnik J; Division of Cancer Sciences, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
  • Vasiljevic A; Department of Pediatric Hematology and Oncology, Alder Hey Children's NHS Foundation Trust, Liverpool, UK.
  • Fenouil T; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Meyronet D; Department of Pathology, Amsterdam University Medical Centers, Location VUmc and Brain Tumor Center Amsterdam, Amsterdam, The Netherlands.
  • von Hoff K; Department of Pediatric Oncology and Hematology, Skåne University Hospital, Lund University, Lund, Sweden.
  • Schüller U; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Loiseau H; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Figarella-Branger D; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Kramm CM; Prague Brain Tumor Research Group, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic.
  • Sturm D; Department of Pediatric Haematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic.
  • Scheie D; Department of Pathology and Molecular Medicine, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic.
  • Rauramaa T; Institut de Pathologie Multisite-Site Est, Groupement Hospitalier Est, Hospices Civils de Lyon, Lyon, France.
  • Pesola J; Institut de Pathologie Multisite-Site Est, Groupement Hospitalier Est, Hospices Civils de Lyon, Lyon, France.
  • Gojo J; Institut de Pathologie Multisite-Site Est, Groupement Hospitalier Est, Hospices Civils de Lyon, Lyon, France.
  • Haberler C; Department of Pediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Brandner S; Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Jacques T; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Sexton Oates A; Research Institute Children's Cancer Center Hamburg, Hamburg, Germany.
  • Saffery R; University of Bordeaux, Bordeaux Institute of Oncology (BRIC)-INSERM U1312 Université de Bordeaux, 146 rue Leo Saignat, Case 76, 33076, Bordeaux, France.
  • Koscielniak E; Aix-Marseille Univ, APHM, CNRS, INP, Inst Neurophysiopathol, CHU Timone, Service d'Anatomie Pathologique et de Neuropathologie, Marseille, France.
  • Baker SJ; Division of Pediatric Hematology and Oncology, University Medical Center Göttingen, Göttingen, Germany.
  • Yip S; Hopp Children's Cancer Center Heidelberg (KiTZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.
  • Snuderl M; Division of Pediatric Glioma Research (B360), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.
  • Ud Din N; Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, University Hospital Heidelberg, Heidelberg, Germany.
  • Samuel D; Department of Pathology, Rigshospitalet, Copenhagen, Denmark.
  • Schramm K; Department of Clinical Pathology, Kuopio University Hospital and Unit of Pathology, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.
  • Blattner-Johnson M; Department of Pediatrics, Pediatric Hematology and Oncology Ward, Kuopio University Hospital and Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.
  • Selt F; Department of Pediatrics and Adolescent Medicine, Comprehensive Cancer Center and Comprehensive Center for Pediatrics, Medical University of Vienna, 1090, Vienna, Austria.
  • Ecker J; Division of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, Vienna, Austria.
  • Milde T; Division of Neuropathology, National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, Queen Square, London, UK.
  • von Deimling A; Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, Queen Square, London, UK.
Acta Neuropathol ; 145(4): 511-514, 2023 Apr.
Article en En | MEDLINE | ID: mdl-36786841